Fidelity Investments’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852 | Buy |
+501
| New | +$852 | ﹤0.01% | 4979 |
|
|
2024
Q2 | – | Sell |
-161
| Closed | -$1.08K | – | 5350 |
|
|
2024
Q1 | $1.08K | Buy |
+161
| New | +$1.08K | ﹤0.01% | 4770 |
|
|
2022
Q1 | – | Sell |
-10
| Closed | -$1K | – | 4921 |
|
|
2021
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 4086 |
|
|
2021
Q1 | – | Sell |
-63,064
| Closed | -$6.21M | – | 3951 |
|
|
2020
Q4 | $6.21M | Sell |
63,064
-94,933
| -60% | -$9.34M | ﹤0.01% | 2121 |
|
|
2020
Q3 | $76M | Buy |
157,997
+87
| +0.1% | +$41.9K | 0.01% | 1046 |
|
|
2020
Q2 | $122M | Buy |
157,910
+6,587
| +4% | +$5.11M | 0.01% | 803 |
|
|
2020
Q1 | $105M | Buy |
151,323
+44,202
| +41% | +$30.7M | 0.01% | 735 |
|
|
2019
Q4 | $98.3M | Buy |
+107,121
| New | +$98.3M | 0.01% | 917 |
|